Proteins potentiated by epidermal growth. factor (EGF) to induce a transformed phenotype in non-neoplastic rat kidney fibroblasts in cell culture have been isolated from many non-neoplastic tissues of the adult mouse, including submaxillary gland, kidney, liver, muscle, heart, and brain. They resemble previously described transforming growth factors (TGFs) isolated from neoplastic cells as follows: they are extractable by acid/ ethanol and are acid-stable, low molecular weight (6000-10,000) polypeptides requiring disulfide bonds for activity, and they cause anchorage-independent growth of non-neoplastic indicator cells that will not grow in soft agar in their absence. Partial purification of these TGFs from submaxillary glands of male mice shows that they are distinct from EGF. Unlike previously described extracellular TGFs, but like certain cellular TGFs from neoplastic cells, they are potentiated by EGF in their ability to promote anchorageindependent growth. The isoelectric point of the submaxillary gland TGF protein is near neutrality. Chromatography on Bio-Gel P-30 followed by high-pressure liquid chromatography has resulted in a 22,000-fold overall purification. The most purified protein is active in inducing growth in soft agar at 1 ng/ml when assayed in the presence of EGF. The data add further evidence to the concept that neoplasia may result from a quantitative, rather than qualitative, alteration in non-neoplastic biochemical processes. We have recently described (1) the isolation and characterization of a set of low molecular weight, acid-stable polypeptides, called transforming growth factors (TGFs), from several neoplastic mouse tissues including fibroblasts transformed by Moloney sarcoma virus (MSV) and a transplantable bladder carcinoma originally induced by a chemical carcinogen. These polypeptides are intracellular proteins that are extractable by acid/ethanol. Similar extracellular transforming polypeptides, called sarcoma growth factors (SGFs), were first isolated by De Larco and Todaro (2) from the conditioned medium of MSVtransformed mouse fibroblasts grown in culture. Several other extracellular transforming polypeptides derived from neoplastic cells ofboth human (3) and animal (4) origin have been reported recently.
Using methods essentially identical to those previously used for the isolation and characterization of TGFs from neoplastic tissues (1), we have found a related set of intracellular TGFs from many non-neoplastic tissues of the adult mouse, including skeletal muscle, heart, liver, kidney, brain, and submaxillary gland. Particular attention was given to the submaxillary gland because a number of biologically active peptides have been isolated from this tissue (8, 9) . The TGFs isolated from nonneoplastic cells resemble the intracellular TGFs from neoplastic cells; when assayed in the presence of epidermal growth factor (EGF) they are equally potent inducers of anchorage-independent growth of untransformed, non-neoplastic, indicator cells. This property clearly distinguishes the TGFs from many other known mitogenic growth factors such as insulin, the insulin-like growth factors, platelet-derived growth factor, nerve growth factor, fibroblast growth factor, and EGF, none of which have this property (unpublished data).
MATERIALS AND METHODS Extraction and Gel Exclusion Chromatography of Mouse Tissues. Mature male Swiss Webster mice were given an intraperitoneal injection of 10 mg of testosterone propionate in sesame oil (10) . One week later, the mice were killed by CO2 narcosis; the excised tissues were immediately frozen and stored over liquid nitrogen. The tissues were powdered at liquid nitrogen temperature (Tekmar laboratory mill with cryostatic attachment) before extraction with acid/ethanol, precipitation with ethanol and ether, dialysis, and lyophilization of the extract, as described for the extraction of TGFs from neoplastic cells (1) . Chromatography on Bio-Gel P-60 or P-30 (100-200 mesh) was done with upward flow of 1 M acetic acid on 2.5 x 70 cm or 5.0 x 90 cm columns at flow rates of 15 or 35 ml/ hr (1) . Protein concentrations in all assays were determined by dye binding (11) with bovine serum albumin as standard.
Soft Agar Assay. Assay for growth of anchorage-dependent rat kidney fibroblasts, clone 49 F, in soft agar medium was modified from that described (1) . Cells were stained after 7 days (12), and colonies were counted and measured by using a Bausch and Lomb Omnicon image analysis system consisting of a light microscope with attached television camera, image analyzer, and data terminal. The field was displayed two-dimensionally, and all values were derived from the area of the colony cross section. The image analyzer system was programmed to size colonies on a logarithmic scale from 500 pum2 to a maximum of 353,000 /Im2 in 25 categories and to determine the mean colony size from the data obtained from each plate. A total area of 0.5 cm2 was read for each plate in 15 separate fields; the data represent a compilation ofthe averages ofthree counts ofeach field.
Abbreviations: MSV, Moloney sarcoma virus; SGF, sarcoma growth factor; TGF, transforming growth factor; EGF, epidermal growth factor; HPLC, high-pressure liquid chromatography; RSV, Rous sarcoma virus.
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In the absence ofany added growth factors, few cells undergo even a single cell division. The addition of TGFs to the assay produces a dose-dependent increase in both mean colony size and absolute number ofcolonies. Colonies larger than 9000 ,&m2 (0.1 mm in dia~meter) were determined to have particular significance for the assay ofEGF-potentiated TGF'activity because the background level of EGF-induced colonies of this size is low. Within-a particular assay, the number of colonies or the mean colony size determined on duplicate plates typically agreed within 5-10%. Although the maximal'cellular response to TGFs showed'some variation from assay to assay, both the median and relative positions of the dose-response curves remained essentially unchanged.
Epidermal Growth Factor (EGF). EGF was extracted from the submaxillary gland of' male mice together with TGFs by using the same acid/ethanol extraction procedure and chromatography on polyacrylamide gels in 1 M acetic acid as described for TGFs (1) . EGF was retained on the Bio-Gel P-60 column and eluted just after the salt peak (see Fig. 2A RESULTS Acid/ethanol extracts of all non-neoplastic mouse tissues stimulated anchorage-independent growth of rat kidney fibroblasts in soft agar. EGF, 'Fwhich potentiates the ability of certain cellular TGFs from neoplastic tissues to induce the formation of large colonies in soft agar (unpublished data), was found here to be a strong determinant of the activities of the TGFs from non-neoplastic mouse tissues. When assayed'in the absence of added EGF, extracts ofkidney, liver, muscle, and submaxillary gland all had a higher apparent specific activity in the soft-agar assay than did cellular SGF'extracted from neoplastic mouse 3T3 cells (1) (Fig. 1A ). However, a parallel soft-agar assay carried out in the presence of EGF at 2 ng/ml [a concentration shown to be optimal for the potentiation ofthe TGF-induced response (unpublished' data)] showed that the specific activity of the extracts from all the non-neoplastic tissues was approximately equal to that ofthe cellular SGF (Fig. 1B) . EGF itselfstimulated only minimal formation oflarge colonies (Fig. 1B) . The disparity between the results obtained in the presence and absence of EGF can be explained, in part, by the EGF'levels of the crude acid/ethanol extracts of each of these tissues (Table 1 ). There was sufficient intrinsic EGF'in extracts of the submaxillary gland or kidney for full potentiation of the TGFs from these tissues in the soft-agar assay. Extracts of tissues such as liver, muscle, brain, and heart contained only very low amounts of EGF, and the crude cellular SGF contained essentially none. Comparison of Fig. 1 A and B, as well as the data in Table 1, shows that the specific activity of those tissue extracts low in EGF is markedly increased in the presence of EGF. In the presence of optimal concentrations of EGF; the specific activities ofacid/ethanol extracts ofliver, muscle, heart, brain, submaxillary gland, and kidney all were similar to the specific activity of extracts of transformed cells, represented by cellular SGF. Also, like the cellular SGF (1) and other TGFs (1-3) isolated from neoplastic tissues, the activities of the TGFs from non~neoplastic tissues were <5% ofthe controls after treatment with either trypsin or dithiothreitol (data not shown).
Chromatography of the acid/ethanol extracts of mouse-submaxillary gland ( Fig. 2A) and kidney (Fig. 2B) on Bio-Gel P-60 columns in 1 M acetic acid showed that, like the cellular SGF (1), the soft-agar colony-forming-activity eluted from the column in a broad profile after the RNase marker (Mr, 13, 000) and just Protein, &g/ml before the insulin marker (Mr 6,000),.having an apparent Mr of 7000-10,000. EGF, determined by radioimmunoassay, eluted from the Bio-Gel P-60 column after the salt peak, as reported by Savage and Cohen, who used Bio-Gel P-10 in a different solvent system (13) . Although Fig. 2A shows that EGF and the TGF activity of submaxillary gland extracts were generally sepairated on a Bio-Gel column, nanogram amounts of EGF could be.detected by radioimmunoassay in the region ofTGF activity (less than 1% of the EGF on the column). This minute amount of EGF was sufficient for optimal potentiation of the submaxillary gland TGF activity in the soft-agar assay, thus making it insensitive to the addition of EGF (2 ng/ml) (see Fig. 5 ). A similar effect was seen with the pooled TGFs from Bio-Gel chromatography ofkidney extracts, even though the kidney extracts contained less than 0.1% of the EGF of the submaxillary gland (Table 1) .
Isoelectric focusing of the pooled TGFs from Bio-Gel P-30 chromatography of the submaxillary gland extract showed that the major TGF activity potentiated by EGF focused at an isoelectric point ofapproximately 6.8-7.4 (Fig. 3A, fractions 7-10 (Fig. 3B) , in good agreement with published values (16) . As, reported elsewhere (unpublished data), 'in soft agar, EGF itselfis'able to induce the formation only ofsmall colonies (mean size 2000-3000 ILm2), and the response is independent of EGF concentration in the range 2-100 ng/ml. However, in the presence, of optimal TGF levels or suboptimal concentrations of TGFs in combination with EGF, a dose-dependent response of large colonies (>9000 ,um2) can be demonstrated. A similar phenomenon can be seen in Fig. 3A , where it is shown that pooled submaxillary glandifractions 7-10 (neutral isoelectric point), assayed in the presence of EGF at 2 ng/ml, caused a dose-dependent formation of large colonies in the soft-agar assay, whereas pooled fractions [15] [16] [17] [18] [19] [20] (EGF region) behaved similarly to known EGF in the assay, causing dose-independent formation of small colonies (unpublished data). HPLC also gave an excellent separation ofTGFs-from contaminating EGF and. other unwanted.proteins still remaining in submaxillary gland extracts after purification by gel exclusion chromatography (Fig. 4) . The submaxillary gland TGF purified by HPLC was markedly potentiated (18-fold) by EGF in the soft agar assay (Fig. 5) , as reported for partially purified preparations of cellular SGF and a TGF derived from'bladder carcinomas (unpublished data). It had measurable activity in the soft-agar assay at a concentration of'18 ng/ml in the absence of'EGF and at approximately 1 ng/ml in the presence of EGF at 2 ng/ml. The overall purification ofthe TGF fromthe submaxillary gland was approximately 2200-fold from the crude acid/ethanol extract or approximately 22,000-fold from the original tissue (Fig.  5B) . It is expected that one or two additional purification steps will result in a homogeneous preparation. Preliminary results with ,t Bondapak C18 columns and acetonitrile gradients in 0.1% trifluoroacetic acid show that excellent separation and recovery of TGFs from other proteins can be obtained (17) . The data. in Fig. 5 emphasize the need for assessing the degree of purification of this class ofTGFs by assay in the presence of the synergistic growth factor EGF, whose ubiquitous presence in the initial steps ofpurification results in an amplification ofthe TGF activity over the intrinsic activity ofthese factors once they have been freed of contaminating EGF. DISCUSSION The results presented indicate that transforming polypeptides, which are potentiated by EGF to stimulate anchorage-independent, growth of untransformed indicator cells, can be extracted from many non-neoplastic tissues of the adult mouse. Although the assayable level of such transforming activity in crude extracts appears to differ from tissue to tissue, when EGF is included at optimal levels in the soft-agar assay a similar level of transforming activity is found in: the different tissues. Characterization thus far of the transforming polypeptides extracted from non-neoplastic mouse tissues, such. as the submaxillary gland and kidney, indicates. that they are similar to peptides found in neoplastic mouse tissues, such as the cellular SGFs derived from virus-transformed fibroblasts (1). Transforming polypeptides extracted from both neoplastic and non-neoplastic mouse tissues have similar molecular weights (as determined by gel exclusion chromatography) and are dependent on integrity ofdisulfide bonds for activity. As reported here, one class The sample (1.2 mg) was dissolved in 250 jul of 24% n-propanol in 0.1% aqueous trifluoroacetic acid and injected onto an analytical pBondpak CN column, 3.9 x 300 mm. The column was developed with a gradient of 24-48% n-propanol (dashed line) in aqueous 0.1% trifluoroacetic acid over 40 min. Aliquots (50 Al) of the 1-ml fractions were usedfor determination of soft, agar activity (e), EGF by radioimmunoassay (A), and protein (o).
ofTGFs is markedly potentiated.in activity by nanogram levels ofEGF, which in itself-is not a potent.TGF. Although the amino acid sequence of any of the TGFs remains to be determined; the ability to purify these peptides on HPLC which we have demonstrated in.the present study indicates that this should be an attainable goal once the preparations can be scaled up to larger amounts.
The finding of TGFs in many non-neoplastic tissues of an adult animal at first may seem surprising, but it is not unexpected in light of new insights regarding the molecular biology of the transforming.(src) genes of RNA tumor viruses. Indeed, recent studies on the src gene products in both avian (18, 19) and rat (20, 21) Fig. 2A (A) ; and peak fractions from HPLC purification, as shown in Fig. 4'(c) (18) . The RSV src gene appears to be derived from a cellular gene that, in uninfected, non-neoplastic cells, expresses a phosphoprotein phosphokinase structurally and functionally closely related to the RSV transforming gene product, the protein kinase pp6OarC (19) .
Moreover, in several other non-neoplastic cells, regulatory polypeptides have been found that bear close relationship to gene products derived from transforming (src) genes. EGF recently has been shown to activate an endogenous cell membrane kinase which then phosphorylates tyrosine residues on a target protein molecule (22, 23) , in a manner analogous to avian RSV pp6O0 (18, 19 (25) . Also, it may be possible to use these polypeptides in a therapeutic manner to repair tissue damage, as in wound healing of various types.
All of these problems will require further laboratory investigation. The following would appear to be key problems: (i) the determination of the primary structures and, in particular, any sequence homologies of TGFs from both neoplastic and nonneoplastic tissues; (ii) the control of synthesis, processing, and 
